Holen Sie sich die Stockscreener-App
5.5459
5.93%
0.3209
Vanda Pharmaceuticals Inc Aktie (VNDA) Neueste Nachrichten
Stonepine Capital Management LLC Has $1.18 Million Position in Vanda Pharmaceuticals Inc. $VNDA - MarketBeat
What insider trading reveals about Vanda Pharmaceuticals Inc. stockStop Loss & Real-Time Volume Surge Alerts - Newser
Vanda Pharmaceuticals (VNDA) Soars After FDA Lifts Tradipitant H - GuruFocus
Vanda jumps as FDA lifts tradipitant partial clinical hold - Seeking Alpha
Vanda Says FDA Lifts Partial Hold on Tradipitant Motion-Sickness Study - marketscreener.com
FDA lifts partial clinical hold on Vanda’s tradipitant for motion sickness - Investing.com India
FDA Lifts Hold on Vanda’s Tradipitant Trials - TipRanks
FDA Lifts Hold on Vanda Pharmaceuticals' (VNDA) Tradipitant Stud - GuruFocus
Vanda Pharmaceuticals stock rises after FDA lifts partial clinical hold By Investing.com - Investing.com Canada
FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness - PR Newswire
Will Vanda Pharmaceuticals Inc. (VM4) stock see insider accumulation2025 EndofYear Setup & High Conviction Trade Alerts - Newser
Vanda Pharmaceuticals (VNDA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Vanda Pharmaceuticals Inc. (VM4) stock attractive for growth fundsMarket Activity Report & Low Risk Growth Stock Ideas - Newser
Will Vanda Pharmaceuticals Inc. (VM4) stock benefit from mergersWeekly Stock Report & Weekly Setup with High ROI Potential - Newser
Can Vanda Pharmaceuticals Inc. (VM4) stock double in coming years2025 Risk Factors & Free Long-Term Investment Growth Plans - Newser
How Vanda Pharmaceuticals Inc. (VM4) stock reacts to new regulations2025 Volatility Report & Daily Oversold Bounce Ideas - Newser
How Vanda Pharmaceuticals Inc. (VM4) stock moves in volatile trading sessionsPortfolio Gains Summary & AI Optimized Trading Strategy Guides - Newser
How Vanda Pharmaceuticals Inc. (VM4) stock reacts to weak economy - Newser
How Vanda Pharmaceuticals Inc. (VM4) stock reacts to monetary easingProfit Target & Risk Controlled Stock Alerts - Newser
Will Vanda Pharmaceuticals Inc. stock pay special dividends - Newser
H.C. Wainwright reiterates Buy rating on Vanda Pharmaceuticals stock By Investing.com - Investing.com Canada
Vanda Pharmaceuticals (Nasdaq:VNDA) Provides Key Regulatory Update on Motion Sickness Therapy - Kalkine Media
Vanda Pharmaceuticals Says FDA Will Take More Time To Decide On Tradipitant Clinical Hold Re-Review - MSN
FDA Extends Review of Vanda Pharmaceuticals' (VNDA) Tradipitant - GuruFocus
FDA re-review of Vanda tradipitant partial clinical hold extended - Seeking Alpha
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness - GuruFocus
Vanda Pharmaceuticals Updates on Tradipitant FDA Review - TipRanks
Vanda Pharmaceuticals provides regulatory update on Tradipitant for motion sickness - marketscreener.com
Vanda Pharmaceuticals (VNDA) Updates on Tradipitant for Motion S - GuruFocus
Vanda Pharmaceuticals Provides Regulatory Update On Tradipitant For Motion Sickness - TradingView
Vanda Pharmaceuticals Inc Provides Regulatory Update on Tradipitant - TradingView
Vanda (Nasdaq: VNDA) details FDA hold re-review, labeling talks on tradipitant NDA - Stock Titan
Published on: 2025-11-28 08:55:55 - moha.gov.vn
Will Vanda Pharmaceuticals Inc. stock gain from government policiesJuly 2025 Sector Moves & Fast Gaining Stock Reports - BỘ NỘI VỤ
In a Major Win for Vanda, a Federal Appeals Court Overturns FDA's Order Denying Approval of Hetlioz for the Treatment of Jet Lag Disorder (PR Newswire) - Aktiellt
Vanda Sees Sales Jump, But Losses Also Pile Up - Finimize
Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results (PR Newswire) - Aktiellt
Vanda a new buy at B. Riley on 'historic discount' - MSN
Will Vanda Pharmaceuticals Inc. (VM4) stock test record highs in 2025Wall Street Watch & Capital Efficient Trade Techniques - newser.com
Vanda Pharmaceuticals Leads 3 Promising Penny Stocks - Yahoo Finance
VNDA Stock Jumps on Upbeat Tradipitant Data Cutting GLP-1 Side Effects - MSN
Vanda Pharmaceuticals: Commercial Execution Meets Pipeline Optionality (NASDAQ:VNDA) - Seeking Alpha
Vanda Reports Big Win In Wegovy Support Study, Analysts UpbeatVanda Pharmaceuticals (NASDAQ:VNDA) - Benzinga
Is Vanda Pharmaceuticals Inc. (VM4) stock trading at attractive multiples2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
Vanda Pharmaceuticals (VNDA): Evaluating Valuation After Successful Tradipitant Trial Results in GLP-1 Therapy Space - Yahoo Finance
Can Vanda Pharmaceuticals Inc. (VM4) stock withstand sector downturnsWeekly Profit Recap & Verified Technical Trade Signals - newser.com
Will Vanda Pharmaceuticals Inc. (VM4) stock announce special dividendRate Hike & Fast Exit Strategy with Risk Control - newser.com
Is Vanda Pharmaceuticals Inc. stock supported by innovation pipelineOptions Play & Weekly Return Optimization Plans - newser.com
Chart based analysis of Vanda Pharmaceuticals Inc. trendsWeekly Volume Report & Capital Protection Trading Alerts - newser.com
Will Vanda Pharmaceuticals Inc. stock benefit from infrastructure spending2025 Big Picture & Technical Entry and Exit Alerts - newser.com
0.83%
0.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):